Literature DB >> 7539544

A randomized study comparing glucagon and hyoscine N-butyl bromide before endoscopic retrograde cholangiopancreatography.

F Y Chang1, W S Guo, T M Liao, S D Lee.   

Abstract

BACKGROUND: This study tried to resolve whether glucagon is a better premedication for endoscopic retrograde cholangiopancreatography (ERCP).
METHODS: We first measured the basal blood sugar and amylase levels. Then an endoscope was placed in the duodenum without premedication, and basal pulse and duodenal peristaltic rates were measured. ERCP began after studied subjects were randomly premedicated with either 1 mg glucagon (n = 38) or 40 mg hyoscine N-butyl bromide (n = 36) intravenously. Ten minutes later the variables were measured again.
RESULTS: Glucagon elicited hyperglycemia whereas hyoscine N-butyl bromide manifested an anticholinergic effect. No difference was found between these two groups with regard to the necessary interval for ERCP (20.6 +/- 14.1 min versus 21.4 +/- 14.7 min; NS) or the success rate for cholangiopancreatography (92.1% versus 91.7%; NS). Neither hyperamylasemia nor pancreatitis was preventable when glucagon was used.
CONCLUSIONS: The two premedications appear equally effective in the performance of ERCP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539544     DOI: 10.3109/00365529509093278

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Nitroester drug's effects and their antagonistic effects against morphine on human sphincter of Oddi motility.

Authors:  Shuo-Dong Wu; Zhen-Hai Zhang; Dong-Yan Li; Jun-Zhe Jin; Jing Kong; Zhong Tian; Wei Wang; Min-Fei Wang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Administration of hyoscine- n-butylbromide during colonoscopy: a survey of current UK practice.

Authors:  Matthew Robert Bedford; Tristan Reuser; Paul Wilson; Sharad Karandikar; Douglas Bowley
Journal:  Frontline Gastroenterol       Date:  2012-06-16

3.  The Efficacy and Safety of Low Dose versus Usual Dose of Hyoscine During Endoscopic Retrograde Cholangiopancreatography: A Randomized Clinical Trial.

Authors:  Hassan Salmanroghani; Massoud Mirvakili; Mahtabalsadat Mirjalili; Mahmud Baghbanian; Roham Salmanroghani
Journal:  Clin Pharmacol       Date:  2020-08-20

4.  Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial.

Authors:  Tomas Sjöberg Bexelius; John Blomberg; Yun-Xia Lu; Hans-Olof Håkansson; Peter Möller; Carl-Eric Nordgren; Urban Arnelo; Jesper Lagergren; Mats Lindblad
Journal:  World J Gastrointest Endosc       Date:  2012-11-16

5.  The influence of duodenally-delivered Shakuyakukanzoto (Shao Yao Gan Cao Tang) on duodenal peristalsis during endoscopic retrograde cholangiopancreatography: a randomised controlled trial.

Authors:  Haruka Fujinami; Shinya Kajiura; Jun Nishikawa; Takayuki Ando; Toshiro Sugiyama
Journal:  Chin Med       Date:  2017-01-09       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.